Concepedia

Douglas J. Loftus

DJ

Statistics

Publications

14

Citations

1.7K

H-Index

14

Active since

1984

Affiliations

National Institutes of Health(Current)

National Cancer Institute

Fondazione IRCCS Istituto Nazionale dei Tumori

University of Pittsburgh

University of North Carolina at Chapel Hill

Douglas J. Loftus is an author at National Institutes of Health specializing in immunology, life sciences, and cancer immunology.

Publications per year

1984–2016

14

Publications

14

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.

Paul F. Robbins, Mona El‐Gamil, Yongfeng Li et al. · The Journal of Experimental Medicine · 1996 · 548 citations · Full text

, , +17

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.

José Mayordomo, Douglas J. Loftus, Hiroshi Sakamoto et al. · The Journal of Experimental Medicine · 1996 · 256 citations · Full text

, , +17

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35).

Douglas J. Loftus, Chiara Castelli, Timothy M. Clay et al. · The Journal of Experimental Medicine · 1996 · 182 citations · Full text

, , +17

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

Michael L. Salgaller, Patricia A. Lodge, Joanne G. McLean et al. · The Prostate · 1998 · 119 citations

, , +17

A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy.

Licia Rivoltini, P Squarcina, Douglas J. Loftus et al. · PubMed · 1999 · 99 citations

, , +17

1–5 of 14